Cargando…

MON-243 The Difference of Body Mass Index Score before and after Gonadotropin-Releasing Hormone Agonist Treatment in Cerntral Precocious Puberty Girls

Purpose: We investigated the difference of body mass index(BMI) score before and after gonadotropin-releasing hormone agonist (GnRHa) treatment in central precocious puberty girls(CPP). Methods: Medical records of 177 girls with CPP treated with GnRHa were reviewed. All patients completed the therap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Yujung, Kim, Seulki, Lee, Seonhwa, Ahn, Moon Bae, Kim, Shin-Hee, Cho, Kyoungsoon, Cho, Wonkyoung, Jung, Min-Ho, Suh, Byung-Kyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Pediatric Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550710/ http://dx.doi.org/10.1210/js.2019-MON-243

Ejemplares similares

MON-113 The Effect of Body Mass Index on the Peak Growth Hormone Level After Growth Hormone Stimulation Test in Children with Short Stature
por: Lee, Nayeong, et al.
Publicado: (2020)

SAT-249 Comparison of Different Criteria for the Definition of Insulin Resistance and Its Relation with Metabolic Risk in Overweight and Obese Adolescents
por: Lee, Seonhwa, et al.
Publicado: (2019)

LBODP081 The Relationship Between Body Mass Index Changes And Bone Age Progression During Gonadotropin-releasing Hormone Agonist Treatment In Girls With Idiopathic Central Precocious Puberty
por: Kim, Seulki, et al.
Publicado: (2022)

The influence of gonadotropin-releasing hormone agonists on anthropometric change in girls with central precocious puberty
por: Yoon, Jong Wan, et al.
Publicado: (2017)

Treatment outcomes of gonadotropin-releasing hormone agonist in obese girls with central precocious puberty
por: Kim, Hye Ryun, et al.
Publicado: (2017)

MON-241 Relationship between Final Height and Birth Weight after Gonadotropin-Releasing Hormone Agonist Treatment in Girls with Central Precocious Puberty
por: Kim, Eun Young, et al.
Publicado: (2019)

Effect of gonadotropin-releasing hormone agonist treatment on near final height in girls with central precocious puberty and early puberty
por: Yang, Eun Hye, et al.
Publicado: (2023)

The influence of gonadotropin releasing hormone agonist treatment on the body weight and body mass index in girls with idiopathic precocious puberty and early puberty
por: Kim, Sung Woo, et al.
Publicado: (2017)

Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone agonist with or without growth hormone
por: Jung, Mo Kyung, et al.
Publicado: (2014)

Relationship between final adult height and birth weight after gonadotropin-releasing hormone agonist treatment in girls with central precocious puberty
por: Cho, Ah Young, et al.
Publicado: (2020)

Effects of Gonadotropin-Releasing Hormone Agonist Therapy on Body Mass Index and Height in Girls with Central Precocious Puberty
por: Lee, Seung Jae, et al.
Publicado: (2012)

Increased final adult height by gonadotropin-releasing hormone agonist in girls with idiopathic central precocious puberty
por: Lee, Hae Sang, et al.
Publicado: (2018)

Prevalence of idiopathic scoliosis in girls with central precocious puberty: effect of a gonadotropin-releasing hormone agonist
por: Chung, Lindsey Yoojin, et al.
Publicado: (2020)

Commentary on "Effect of gonadotropin-releasing hormone agonist treatment on near final height in girls with central precocious puberty and early puberty"
por: Kwon, Ahreum
Publicado: (2023)

Clinical data and basal gonadotropins in the diagnosis of central precocious puberty in girls
por: Durá-Travé, Teodoro, et al.
Publicado: (2021)

Long-term effects of gonadotropin-releasing hormone analogs in girls with central precocious puberty
por: Kim, Eun Young
Publicado: (2015)

Effect of gonadotropin-releasing hormone agonist monotherapy and combination therapy with growth hormone on final adult height in girls with central precocious puberty
por: Cho, Ah Young, et al.
Publicado: (2023)

Final height after gonadotropin-releasing hormone agonists with or without growth hormone in Korean girls with central precocious puberty and early puberty
por: Kwon, Eun Byul, et al.
Publicado: (2015)

SUN-724 Associations of GPR174 and ITM2A Genes on X Chromosome with Early Onset Autoimmune Thyroid Disease in Korean
por: Lee, Nayeong, et al.
Publicado: (2020)

Influence of Gonadotropin Hormone Releasing Hormone Agonists on Interhemispheric Functional Connectivity in Girls With Idiopathic Central Precocious Puberty
por: Chen, Tao, et al.
Publicado: (2020)

Precocious puberty in girls
por: Chittwar, Sachin, et al.
Publicado: (2012)

Short-term efficacy of 1-month and 3-month gonadotropin-releasing hormone agonist depots in girls with central precocious puberty
por: Jeon, Min Jin, et al.
Publicado: (2021)

SAT-304 Unexplained Asymptomatic Hyperestrogenism in Central Precocious Puberty Patient Treated with Gonadotropin Releasing Hormone Agonist
por: Kim, Dae Hyun, et al.
Publicado: (2019)

Effects of gonadotropin-releasing hormone agonist treatment on final adult height in boys with idiopathic central precocious puberty
por: Cho, Ah Young, et al.
Publicado: (2021)

Findings of Brain Magnetic Resonance Imaging in Girls with Central Precocious Puberty Compared with Girls with Chronic or Recurrent Headache
por: Kim, Shin-Hee, et al.
Publicado: (2021)

Single random measurement of urinary gonadotropin concentration for screening and monitoring girls with central precocious puberty
por: Lee, Se Young, et al.
Publicado: (2021)

Body image and depression in girls with idiopathic precocious puberty treated with gonadotropin-releasing hormone analogue
por: Choi, Min-Seon, et al.
Publicado: (2016)

Effect of gonadotropin-releasing hormone agonist therapy on body mass index and growth in girls with idiopathic central precocious puberty
por: Anık, Ahmet, et al.
Publicado: (2015)

Pelvic Ultrasound in Diagnosing and Evaluating the Efficacy of Gonadotropin-Releasing Hormone Agonist Therapy in Girls With Idiopathic Central Precocious Puberty
por: Yu, Hong-kui, et al.
Publicado: (2019)

Etiology and therapeutic outcomes of children with gonadotropin-independent precocious puberty
por: Kang, Eungu, et al.
Publicado: (2016)

Gonadotropin-releasing Hormone Stimulation Test for Precocious Puberty
por: Kim, Han Kyul, et al.
Publicado: (2011)

Factors that predict a positive response on gonadotropin-releasing hormone stimulation test for diagnosing central precocious puberty in girls
por: Suh, Junghwan, et al.
Publicado: (2013)

Change in body mass index and insulin resistance after 1-year treatment with gonadotropin-releasing hormone agonists in girls with central precocious puberty
por: Park, Jina, et al.
Publicado: (2017)

Significant adverse reactions to long-acting gonadotropin-releasing hormone agonists for the treatment of central precocious puberty and early onset puberty
por: Lee, Ji Woo, et al.
Publicado: (2014)

Psychosocial Aspects in Girls with Idiopathic Precocious Puberty
por: Kim, Eun Young, et al.
Publicado: (2012)

LIN28B polymorphisms are associated with central precocious puberty and early puberty in girls
por: Park, Sung Won, et al.
Publicado: (2012)

Thyroid function in girls with central precocious puberty
por: Jung, Geehae, et al.
Publicado: (2019)

Myopic Progression in Girls with Gonadotrophin-Releasing Hormone Agonist Treatment for Central Precocious Puberty
por: Chung, Seung Ah, et al.
Publicado: (2021)

Age of menarche and near adult height after long-term gonadotropin-releasing hormone agonist treatment in girls with central precocious puberty
por: Baek, Joon-Woo, et al.
Publicado: (2014)

Dual effects of a gonadotropin-releasing hormone agonist on an adolescent girl with pelvic congestion syndrome and precocious puberty: a case report
por: Yu, Jwo-Huey, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f41o09hifa58q7te4jqf7ta18m